| Literature DB >> 30270580 |
Abstract
Since the mid 1980s, the prevalence of liver abscess caused by hypervirulent Klebsiella pneumoniae strain has increased in Asia, particularly in Taiwan and Korea. This strain is mostly K1 or K2 serotype, and has hypercapsular and hypermucoid phenotypes. Most infections are community acquired, and patients rarely have a hepatobiliary disease prior to infection. Clinical manifestations are characterized by fever and high C-reactive protein, and metastatic infections, such as septic emboli in the lung and endophthalmitis and meningitis are frequently observed. Antibiotic resistance is rare. Antibiotic treatment and abscess drainage are needed, and early diagnosis and treatment of endophthalmitis is also important.Entities:
Keywords: C-reactive protein; Klebsiella pneumoniae; Liver Abscess
Year: 2018 PMID: 30270580 PMCID: PMC6167513 DOI: 10.3947/ic.2018.50.3.210
Source DB: PubMed Journal: Infect Chemother ISSN: 1598-8112
Figure 1Routes of Infection (adapted from reference 8).
Characteristics of classical and hypervirulent Klebsiella pneumoniae strains
| Parameter | Characteristics for strain type | |
|---|---|---|
| Classical | Hypervirulent | |
| Common types of infection | Pneumonia, UTI, bacteremia | Pyogenic liver abscess, bacteremia, pneumonia, necrotizing fasciitis, myositis, meningitis, endophthalmitis |
| Susceptible population | Immunosuppressed (diabetics, patients with malignancies) | Diabetics, healthy people |
| Capsule type | Capsule serotypes K1-K78 | Hypercapsular serotype K1 (93%) or K2 |
| Siderophores (% of strains expressing siderophore) | Enterobactin (100), yersiniabactin (17–46), salmochelin (2–4), aerobactin (6) | Enterobactin (100), yersiniabactin (90), salmochelin (>90), aerobactin (93–100) |
| Primary acquired infection type | Nosocomial | Community acquired |
| Geographic concentration | Worldwide | Primarily Taiwan, Korea, and Southeast Asia |
| Frequency of reports of antibiotic resistance | Frequent (ESBL and carbapenemase producing) | Infrequent |
UTI, urinary tract infections; ESBL, extended-spectrum beta-lactamases.
Figure 2Mucoid phenotype of Klebsiella pneumoniae (adapted from reference 30).